SAN FRANCISCO, Feb. 9, 2011 /PRNewswire/ -- SYNARC, the world's leading provider of medical image analysis services to the pharmaceutical and biotechnology industries, announced today that Ciaran Cooper has joined SYNARC to lead the sales and marketing efforts in support of the company's rapidly growing business in imaging services for clinical trials.
Ciaran Cooper, a pioneer in the clinical trials imaging services industry, brings over 20 years experience in medical imaging with an emphasis in business development, strategic planning, and management. He co-founded MIICRO, Inc. in 1994, the first imaging CRO specialized in early phase translational imaging with FDG PET. Since then, Cooper has worked for several imaging core labs as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.
"I'm thrilled to be joining SYNARC at this exciting time in their development," said Cooper. "SYNARC has always maintained a reputation for science-led, high quality service across a range of therapeutic areas and indications. In the last several years, they have successfully expanded their focus to include oncology and cardiology on top of their historic dominance in musculoskeletal and neurology – few people know how much oncology and cardiology work SYNARC is already engaged in; that's an exciting message to carry out to our customers. To be surrounded by so many bright minds all focused on delivering the highest level of quality to our customers is a dream come true. I'm really proud to be a part of this team."
Aaron Timm, Head of Imaging for CCBR-SYNARC, stated, "Ciaran offers us a very unique perspective on the industry. He has a vast knowledge of the imaging service arena and his reputation for hard work, creativity, and integrity fit well with our team. We're very happy to welcome him aboard."
CCBR-SYNARC's medical image analysis, biochemical marker, and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. CCBR-SYNARC has partnered with industry leaders to bring numerous leading compounds to market across a broad spectrum of therapeutic areas. Our services integrate critical aspects of clinical-trial design and execution, from protocol design and subject recruitment to regulatory liaison on behalf of our clients. Our expert radiologists and scientists are innovators in all aspects of medical image analysis and biochemical markers in drug development, and have pioneered many methods used in today's clinical trials.